Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Determining the Maximum Tolerable Dose and Pharmacokinetic Parameters of Intravenous PTHrP(1-36)"

NCT00177411 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00177411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00177411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Determining the Maximum Tolerable Dose and Pharmacokinetic Parameters of Intravenous PTHrP(1-36)"
Lead sponsor
University of Pittsburgh
Phase
Phase 1
Overall status
Withdrawn
Start date
July 31, 2005
Completion date
July 31, 2007
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis